Hanqi Lei

450 total citations
29 papers, 264 citations indexed

About

Hanqi Lei is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Hanqi Lei has authored 29 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Hanqi Lei's work include Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Hanqi Lei is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Nanoplatforms for cancer theranostics (5 papers). Hanqi Lei collaborates with scholars based in China, Hong Kong and Japan. Hanqi Lei's co-authors include Jun Pang, Fucai Tang, Zechao Lu, Zhaohui He, Guohua Zeng, Binyuan Yan, Shiqiang Zhang, Yupeng Guan, Xiangwei Yang and Hai Huang and has published in prestigious journals such as Nano Letters, Oncogene and Journal of Controlled Release.

In The Last Decade

Hanqi Lei

25 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanqi Lei China 11 118 109 49 45 44 29 264
Lanqing Cao China 10 121 1.0× 60 0.6× 66 1.3× 48 1.1× 40 0.9× 21 281
J. Good United Kingdom 8 98 0.8× 73 0.7× 95 1.9× 41 0.9× 39 0.9× 14 296
Anchal Ghai United States 9 106 0.9× 104 1.0× 75 1.5× 26 0.6× 66 1.5× 17 289
Shuguang Ju China 12 79 0.7× 60 0.6× 79 1.6× 58 1.3× 33 0.8× 39 368
Shaomin Che China 12 155 1.3× 57 0.5× 112 2.3× 58 1.3× 57 1.3× 17 355
Xiuling Lv China 12 146 1.2× 117 1.1× 49 1.0× 74 1.6× 90 2.0× 14 387
Hongying Zheng China 8 111 0.9× 102 0.9× 119 2.4× 29 0.6× 66 1.5× 23 310
Ryan Robb United States 7 144 1.2× 43 0.4× 105 2.1× 27 0.6× 63 1.4× 18 282
Junyao Xu China 10 185 1.6× 54 0.5× 86 1.8× 28 0.6× 72 1.6× 27 325
Travis Rice‐Stitt United States 9 91 0.8× 71 0.7× 81 1.7× 65 1.4× 73 1.7× 15 296

Countries citing papers authored by Hanqi Lei

Since Specialization
Citations

This map shows the geographic impact of Hanqi Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanqi Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanqi Lei more than expected).

Fields of papers citing papers by Hanqi Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanqi Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanqi Lei. The network helps show where Hanqi Lei may publish in the future.

Co-authorship network of co-authors of Hanqi Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Hanqi Lei. A scholar is included among the top collaborators of Hanqi Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanqi Lei. Hanqi Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Mengjun, Ning Dong, Tongyu Tong, et al.. (2025). A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer. Journal of Health Population and Nutrition. 44(1). 177–177.
3.
Huang, Mengjun, et al.. (2025). Nop2/Sun domain family member 5 contributes to tumorigenic properties in prostate cancer by engaging the PI3K-AKT pathway and tumor-associated macrophages. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(7). 167974–167974. 1 indexed citations
4.
Tong, Tongyu, Hanqi Lei, Zheng Yang, et al.. (2025). HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer. Oncogene. 44(41). 3895–3908.
5.
Zhang, Hao, Chengyuan Xing, Binyuan Yan, et al.. (2024). Paclitaxel Overload Supramolecular Oxidative Stress Nanoamplifier with a CDK12 Inhibitor for Enhanced Cancer Therapy. Biomacromolecules. 25(6). 3685–3702. 4 indexed citations
6.
Yan, Binyuan, et al.. (2024). An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. British Journal of Cancer. 131(5). 870–882. 1 indexed citations
7.
Xing, Chengyuan, Hanqi Lei, Binyuan Yan, et al.. (2024). ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment. Journal of Controlled Release. 368. 637–649. 16 indexed citations
8.
Cao, Fei, Hanqi Lei, Shiqiang Zhang, et al.. (2024). Interpretable multiphasic CT-based radiomic analysis for preoperatively differentiating benign and malignant solid renal tumors: a multicenter study. Abdominal Radiology. 49(9). 3096–3106. 2 indexed citations
9.
Wang, Yiyao, Hanqi Lei, Binyuan Yan, et al.. (2023). Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer. Acta Biomaterialia. 168. 593–605. 27 indexed citations
10.
Guan, Yupeng, Hanqi Lei, Chengyuan Xing, et al.. (2023). Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P‐Glycoprotein and Ferroptosis. Advanced Healthcare Materials. 13(3). e2301345–e2301345. 14 indexed citations
11.
Tang, Fucai, et al.. (2022). A 7-gene signature predicts the prognosis of patients with bladder cancer. BMC Urology. 22(1). 8–8. 11 indexed citations
12.
Zhang, Hao, Hanqi Lei, & Jun Pang. (2022). Diagnostic performance of radiomics in adrenal masses: A systematic review and meta-analysis. Frontiers in Oncology. 12. 975183–975183. 14 indexed citations
13.
Tang, Fucai, Hanqi Lei, Yongchang Lai, et al.. (2021). DNA Methylation Data-Based Classification and Identification of Prognostic Signature of Children With Wilms Tumor. Frontiers in Cell and Developmental Biology. 9. 683242–683242. 4 indexed citations
14.
Lei, Hanqi, Haiyun Xiong, Xing Fu, et al.. (2021). MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer. Computational and Structural Biotechnology Journal. 19. 4941–4953. 12 indexed citations
15.
Lei, Hanqi, Zifeng Wang, Fang Liu, et al.. (2021). CRISPR screening identifies CDK12 as a conservative vulnerability of prostate cancer. Cell Death and Disease. 12(8). 740–740. 30 indexed citations
18.
He, Zhaohui, Fucai Tang, Zechao Lu, et al.. (2018). Analysis of differentially expressed genes, clinical value and biological pathways in prostate cancer.. PubMed. 10(5). 1444–1456. 37 indexed citations
19.
He, Zhaohui, et al.. (2017). Experience of retaining encrusted ureteral stents: URL by 4.5/6.5F ureteroscope can reduce the possibility of PCNL. Urolithiasis. 46(4). 357–361. 5 indexed citations
20.
He, Zhaohui, et al.. (2016). Analysis of repeated renal arteriography after percutaneous nephrolithotomy. Urolithiasis. 45(5). 495–499. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026